We have located links that may give you full text access.
Journal Article
Randomized Controlled Trial
Efficacy of Liuzijue Qigong in Individuals with Chronic Obstructive Pulmonary Disease in Remission.
OBJECTIVES: To investigate the effectiveness of a 6-month Liuzijue qigong (LQG) program in promoting physical and psychosocial function in individuals with chronic obstructive pulmonary disease (COPD).
DESIGN: Single-blind, randomized controlled trial.
SETTING: Seven hospital respiratory care centers in Beijing.
PARTICIPANTS: Individuals with COPD (N = 126; mean age 71.1 ± 2.7, range 65-85).
METHODS: Participants were randomly assigned to one of two groups: LQG (n = 63) and control (n = 63). Subjects in the LQG group received a LQG program consisting of four 45-minute sessions each week and daily walking for 30 minutes for 6 months. Control subjects walked daily for 30 minutes. Data collection was performed at baseline, at 6 weeks, and at 6 months. Primary outcomes involved functional capacity, and secondary outcomes involved quality of life.
RESULTS: The LQG group had greater improvements in the 6-minute walk test (P = .02); specific airway conductance (P = .02); monitored functional task evaluation (P = .04); Medical Outcomes Study 36-item Short-Form Health Survey (SF-36; general health (P < .001), mental health (P = .03)); Chronic Respiratory Questionnaire (dyspnea (P = .05), emotion (P = .05), and mastery (P = .04) at 6-month follow-up. After 6 months, the control group had significant improvement only on the SF-36 mental health (P = .02).
CONCLUSION: LQG promoted functional capacity and quality of life in older adults with COPD at 6 months and is a good alternative home exercise program for older adults in the rehabilitation of COPD.
DESIGN: Single-blind, randomized controlled trial.
SETTING: Seven hospital respiratory care centers in Beijing.
PARTICIPANTS: Individuals with COPD (N = 126; mean age 71.1 ± 2.7, range 65-85).
METHODS: Participants were randomly assigned to one of two groups: LQG (n = 63) and control (n = 63). Subjects in the LQG group received a LQG program consisting of four 45-minute sessions each week and daily walking for 30 minutes for 6 months. Control subjects walked daily for 30 minutes. Data collection was performed at baseline, at 6 weeks, and at 6 months. Primary outcomes involved functional capacity, and secondary outcomes involved quality of life.
RESULTS: The LQG group had greater improvements in the 6-minute walk test (P = .02); specific airway conductance (P = .02); monitored functional task evaluation (P = .04); Medical Outcomes Study 36-item Short-Form Health Survey (SF-36; general health (P < .001), mental health (P = .03)); Chronic Respiratory Questionnaire (dyspnea (P = .05), emotion (P = .05), and mastery (P = .04) at 6-month follow-up. After 6 months, the control group had significant improvement only on the SF-36 mental health (P = .02).
CONCLUSION: LQG promoted functional capacity and quality of life in older adults with COPD at 6 months and is a good alternative home exercise program for older adults in the rehabilitation of COPD.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app